Crisper therapeutics forecast
WebApr 9, 2024 · Gene-editing therapies aren't common today, but years from now that could change. One company that hopes to be at the center of that transition is CRISPR Therapeutics (CRSP-4.27%).The company has ... WebFor CRISPR Therapeutics AG stock forecast for 2024, 9 predictions are offered for each month of 2024 with average CRISPR Therapeutics AG stock forecast of $38.77, a high forecast of $41.94, and a low forecast of $36.13. The average CRISPR Therapeutics AG stock forecast 2024 represents a -10.14% decrease from the last price of …
Crisper therapeutics forecast
Did you know?
WebMay 17, 2024 · 0. 1. 0. 0. These 11 analysts have an average price target of $98.45 versus the current price of CRISPR Therapeutics at $53.45, implying upside. Below is a summary of how these 11 analysts rated ... WebApr 6, 2024 · Analyst Price Forecast Suggests 97.56% Upside As of April 6, 2024, the average one-year price target for Crispr Therapeutics is $85.88. The forecasts range from a low of $39.39 to a high of $231.00.
WebGLOBAL CRISPR MARKET FORECAST 2024-2028 Global CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user … WebMar 30, 2024 · CRISPR Therapeutics AG has been profitable 1 years over the past 10 years. During the past 12 months, the company had revenues of $0.7 million and loss of $5.29 a share.
WebFeb 25, 2024 · CRISPR Therapeutics has the largest market cap of the three, at $10.9B, with a clinical development program that is more advanced than those of Intellia and Editas. CRISPR Therapeutics has already published promising data on the use of CRISPR in β-thalassemia and sickle cell disease in the New England Journal of Medicine. WebCRISPR Therapeutics AG. Institutional investors purchased a net $467.7 thousand shares of CRSP during the quarter ended June 2024. This may signal that the smart money is gaining interest in this ...
WebJun 15, 2024 · CRISPR Therapeutics AG stock rose 26% the last twenty-one trading days (one month), compared to the broader market (S&P500) rise of 4.7%. A change of 26% or more over twenty-one trading days is a ...
WebCRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary. setmywed ceoWebCRSP Stock 12 Months Forecast. $77.69. (71.12% Upside) Based on 17 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 … set my teeth on edge originWebApr 3, 2024 · CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of … set mythical swordWebDec 15, 2024 · In 2015, CRISPR Therapeutics formed a partnership with Vertex Pharmaceuticals (VRTX-0.09%) to develop a number of treatments using this … thethwayoset my web browserWebApr 6, 2024 · CRISPR Therapeutics last posted its earnings results on February 21st, 2024. The reported ($1.41) EPS for the quarter, beating the consensus estimate of ($2.27) by … set my time clockWebApr 12, 2024 · The trading price of CRISPR Therapeutics AG (NASDAQ:CRSP) floating lower at last check on Wednesday, April 12, closing at $44.78, -1.40% lower than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $45.11 and $45.94. ... The company’s revenue is … theth wasserfall